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Introduction
Kinetochores are assembled from multiple distinct protein com-
plexes to form a multivalent microtubule-binding site. Kineto-
chores contact the lateral faces of microtubules, and these initial 
low-affinity contacts are believed to mature to more stable end-
on attachments (for a recent review see Cheeseman and Desai,   
2008). A combination of microtubule- and motor-derived forces 
acting at the kinetochore and along chromosome arms contribute 
to chromosome alignment and establish tension between sister 
chromatids during metaphase (Hays and Salmon, 1990; Sharp 
et al., 2000). The identification of a large number of kinetochore 
proteins from multiple species has greatly advanced our under-
standing of kinetochore structure, yet the rules for assembling 
these complexes are still poorly understood.
In  budding  yeast,  the  centromere  binding  complex  3 
(CBF3) is first assembled before it can bind to sequence-
specific elements on centromeric DNA (CEN-DNA) and recruit 
additional complexes that form a single microtubule-binding 
site (Espelin et al., 1997; Kaplan et al., 1997). After CBF3 
binds to CEN-DNA, the assembly of a functional kinetochore 
is thought to occur in a hierarchical manner, with complexes 
building outwards until a microtubule-binding site forms (Ortiz 
et al., 1999). However, it is interesting to note that relatively 
few mutants completely eliminate kinetochore–microtubule bind-
ing in yeast, which suggests that a strict hierarchy between 
centromeric DNA and microtubule binding may be an over-
simplification. CBF3 is composed of three core subunits, and 
the Hsp90–Sgt1 chaperone complex balances its assembly with 
its turnover (Rodrigo-Brenni et al., 2004). Analysis of recon-
stituted Hsp90–Sgt1 complexes led to the proposed model that 
Sgt1 acts as an adapter, linking Hsp90 to a subset of its clients 
(Catlett and Kaplan, 2006). Sgt1 directly interacts with Hsp90 
and with Skp1, a protein shared with both CBF3 and the SCF 
E3 ubiquitin ligase complex. The SCF-dependent turnover of 
CBF3 subunits suggests that Sgt1 connects Hsp90 clients to 
SCF-mediated  degradation  (Kaplan  et  al.,  1997).  Consistent 
with this idea, mutants that affect the affinity of Sgt1 for Skp1 
favor either assembly or turnover of CBF3 (Rodrigo-Brenni   
et al., 2004).
In contrast to the relatively simple point kinetochores 
that form on sequence-determined centromeres in budding 
yeast, specification of mammalian kinetochores is largely epi-
genetic and is dependent on the proper loading of nucleosomes 
T
he formation of functional kinetochores requires the 
accurate  assembly  of  a  large  number  of  protein 
complexes. The Hsp90–Sgt1 chaperone complex is 
important for this process; however, its targets are not 
conserved and its exact contribution to kinetochore as-
sembly is unclear. Here, we show that human Hsp90–Sgt1 
interacts with the Mis12 complex, a so-called keystone 
complex required to assemble a large fraction of the   
kinetochore. Inhibition of Hsp90 or Sgt1 destabilizes the 
Mis12 complex and delays proper chromosome alignment 
due to inefficient formation of microtubule-binding sites. 
Interestingly, coinhibition of Sgt1 and the SCF subunit, 
Skp1, increases Mis12 complexes at kinetochores and re-
stores timely chromosome alignment but forms less-robust 
microtubule-binding sites. We propose that a balance of 
Mis12 complex assembly and turnover is required for the 
efficient and accurate assembly of kinetochore–microtubule 
binding sites. These findings support a novel role for Hsp90–
Sgt1 chaperones in ensuring the fidelity of multiprotein 
complex assembly.
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of high-affinity microtubule-binding sites after Sgt1 inhibition.   
Interestingly, inhibition of Skp1 reduces the robustness of micro-
tubule attachment sites, arguing that both assembly and turn-
over of Mis12 are important for proper kinetochore function.
Results
Hsp90 is required for Dsn1 stability and 
Mis12 complex localization
Previous  studies  using  Hsp90  inhibitors  and  Sgt1  siRNA 
suggest that the chaperone complex is required for recruit-
ment of both constitutive and outer kinetochore complexes 
(Steensgaard et al., 2004; Niikura et al., 2006). However, be-
cause of the interdependence of kinetochore complexes during 
assembly, it is unclear which kinetochore complex or com-
plexes might require chaperone function. To address this issue, 
we used the rapid kinetics of Hsp90 inhibition by 17-(allyl-
amino)-17-demethoxygeldanamycin  (17-AAG)  to  identify 
kinetochore complexes most immediately affected. After inhi-
bition of Hsp90, clients often exhibit a decrease in protein levels, 
either because they degrade or become insoluble. After treat-
ment of HeLa cells for 12–18 h with 100 nM 17-AAG, immuno-
blotting showed that both outer (e.g., Ndc80
Hec1) and constitutive 
kinetochore complexes (e.g., CENP-K, -H, -U, and -N) remain 
at control levels. In contrast, the Dsn1 subunit of the Mis12 
complex was reduced to 65% of control; the levels of other 
Mis12 subunits were unaffected by 17-AAG (Fig. 1 A). Treat-
ment with 500 nM 17-AAG for 18 h further decreased the 
levels of Dsn1 to less than half (47% of control; Fig. 1 B). 
Consistent with the immunoblots, short-term treatment of cells 
with 500 nM 17-AAG resulted in a general decrease in Mis12 
subunits at kinetochores (Fig. 1 C). It is interesting to note that 
not all Mis12 components behaved the same way after 17-AAG 
treatment; Dsn1 levels at kinetochores were decreased on aver-
age to 78% of control, whereas Nnf1 was more dramatically 
reduced (63% of control; Fig. 1 D). The Nsl1 signal was simi-
larly decreased at kinetochores but was also found in large 
aggregates near chromosomes (Fig. 1 C, arrow). The observed 
heterogeneity suggests that Mis12 subunits have different fates 
in the absence of Hsp90. Overall, these observations support 
the idea that the Mis12 complex, and in particular Dsn1, is a 
target of the Hsp90 chaperone.
Sgt1 inhibition affects the stability of the 
Mis12 complex
We next asked if inhibiting Sgt1 in HeLa cells similarly affected 
the Mis12 complex. After depletion of Sgt1 using siRNA (70% 
reduction; see Fig. 3 C), we observed a similar reduction in 
the fluorescent intensities of Mis12 subunits at the kineto-
chore compared with 17-AAG treatment (compare Fig. 2 A 
and Fig. 1 C). However, the decrease in signals was far more 
dramatic with Sgt1 siRNA; Dsn1, Nnf1, and Nsl1 were a mean 
of 47%, 11%, and 9% of control signals, respectively (Fig. 2 B). 
The differences between Hsp90 and Sgt1 inhibition may reflect 
either the critical targeting role of Sgt1 or the fact that 17-AAG 
can trap Hsp90 client intermediates, resulting in partially formed 
complexes. Regardless of these differences, we conclude that 
containing the histone H3 variant CENP-A (for a review see   
Gieni et al., 2008). The CENP-A nucleosome is required to recruit 
a kinetochore assembly platform in interphase that consists of 
the CENP-H, CENP-M, and CENP-O complexes, also called the 
constitutive centromere complex, or CCAN (Okada et al., 2006; 
Cheeseman and Desai, 2008). Outer kinetochore complexes are 
assembled at centromeres in the G2 stage of the cell cycle (Hori 
et al., 2003; Cheeseman et al., 2004; Yang et al., 2008); Knl1 
and the Mis12 complex are believed to modulate the forma-
tion of the Ndc80 microtubule-binding complex (Cheeseman   
et al., 2006). Rather than forming individual microtubule-binding 
units, electron tomography experiments suggest that micro-
tubule-binding sites form a network that allows both low- and 
high-affinity microtubule interactions (Dong et al., 2007). It has 
been suggested that this architecture allows for an initial low- 
affinity capture of microtubules by kinetochores followed by a 
maturation process that gives rise to high-affinity interactions. 
Implicit in this model is the idea that the proper assembly of a 
kinetochore network is necessary to ensure the efficient forma-
tion of robust microtubule attachment sites.
Experiments to test the interdependency of kinetochore 
proteins on assembly of a microtubule-binding site are also con-
sistent with a network-like organization. For example, inhibi-
tion of the outer kinetochore protein Knl-1 reduces the formation 
of microtubule attachment sites that include Ndc80
Hec1 as well 
as the “keystone” complex, Mis12 (Cheeseman et al., 2008). 
Similarly, the depletion of Mis12 subunits reduces the levels 
of both the outer kinetochore protein Ndc80
Hec1 and the inner 
kinetochore proteins CENP-H and CENP-A (Kline et al., 2006), 
which suggests that kinetochore complexes assemble into an 
interdependent network.
Despite advances in understanding the dependencies of 
kinetochore protein assembly at centromeres, it is less clear 
how individual subunits correctly assemble into subcomplexes 
and then into higher-order structures. The fact that both simple 
and complex kinetochores require Hsp90–Sgt1 suggests that 
chaperones provide a conserved mechanism for assembling large 
protein networks. Although mammalian cells lack a homologue 
of CBF3, inhibition of either Hsp90 or Sgt1 leads to the re-
duction in a large number of kinetochore-associated proteins 
(Steensgaard et al., 2004; Niikura et al., 2006) and reduces 
the efficiency of microtubule attachments. The partial loss 
of microtubule attachment activity suggests that Hsp90–Sgt1 
modulates the efficiency of the higher-order kinetochore assem-
bly required for chromosome alignment. Thus, identification of 
the target of Hps90-Sgt1 will provide important insights into 
the rate-limiting steps required to ensure the efficient assembly 
of kinetochore–microtubule attachment sites.
Using a combination of genetic and biochemical ap-
proaches, we show that the Mis12 complex is the primary target 
of Hsp90–Sgt1 at the kinetochore. Inhibition of either Sgt1 or 
Hsp90 dramatically reduces the levels of Mis12 subunits and 
gives rise to kinetochore defects identical to loss of Mis12 sub-
units. Mis12 complexes interact with both Hsp90 and Sgt1, 
and Sgt1 stabilizes this complex, which is consistent with its 
proposed role as a client adaptor. The SCF component Skp1 
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this possibility, we immunoblotted extracts after treating cells 
with Sgt1 siRNA. We observed a significant decrease in the 
levels of Dsn1 (50% of control; Fig. 3 A), which is comparable 
to 500 nM 17-AAG treatment (Fig. 1 B). Unlike 17-AAG 
treatments, we observed a significant decrease in the levels of 
the localization of Mis12 kinetochore complexes requires the 
function of both Hsp90 and Sgt1.
We reasoned that if Sgt1 targets Hsp90 to Mis12 com-
plexes, then, like 17-AAG treatment, depletion of Sgt1 should 
also destabilize the Dsn1 subunit of the Mis12 complex. To test 
Figure 1.  Hsp90 inhibition decreases Dsn1 levels and Mis12 complex recruitment to the kinetochore. (A) HeLa cells were treated with 100 nM 17-AAG for 
18 h, and extracts were analyzed by immunoblotting for the indicated kinetochore antigens. Asterisks indicate nonspecific background on the immunoblot. 
The fluorescent intensities from the secondary antibody bound to the indicated Mis12 complex subunits were quantified (see Materials and methods) and 
are presented as a percentage signal from the control siRNA treatment. Differences in the amount of extract loaded were normalized using tubulin immuno-
blots. (B) HeLa cells were treated with the indicated concentrations of 17-AAG and analyzed as in A. (C) HeLa cells treated with the 500 nM 17-AAG or 
with carrier alone for 18 h were processed for immunofluorescence using antibodies against the indicated Mis12 subunit, DAPI, and ACA. Merged and 
individual fluorescent images are presented as indicated. The arrow indicates Nsl1 protein aggregates. Bar, 10 µM. (D) The mean maximal fluorescent 
intensities for control cells were set to 100%, and the fraction of signal remaining after 17-AAG treatment was calculated. Error bars represent the deviation 
from the mean observed in multiple kinetochores and cells. This trend was observed in multiple repetitions of the experiment.JCB • VOLUME 189 • NUMBER 2 • 2010   264
If Sgt1 is required to target Mis12 subunits to Hsp90, we 
reasoned that partial depletions of Sgt1 and Hsp90 would ex-
hibit an additive effect on Mis12 instability, or a synthetic inter-
action. We treated cells with siRNA against Sgt1 or Hsp90 for 
just 48 h and observed no decrease in Dsn1 levels when Sgt1 is 
inhibited (not depicted) and only a modest reduction in Dsn1 
when Hsp90 is inhibited (72% of control; Fig. 3 D). However, 
codepleting Sgt1 and Hsp90 results in a 50% decrease of Dsn1 
after 48 h. In addition, codepletion resulted in elevated cell 
the Nsl1 and Nnf1 subunits (59% and 57% of control, respec-
tively) and a moderate reduction of Mis12 (87% of control; 
Fig. 3 A). Again, the more dramatic destabilization may arise 
from the ability of Sgt1 to target Mis12 subunits to Hsp90 and 
thus protect them from degradation. Interestingly, depletion of 
Dsn1, or any other Mis12 component, similarly destabilizes 
all Mis12 subunits (Fig. 3 B); we take this data as evidence 
that protein destabilization is linked to failures in complex as-
sembly (Fig. 3 A).
Figure 2.  Sgt1 depletion prevents efficient Mis12 subunit recruitment to kinetochores. (A) After treatment of HeLa cells with control or Sgt1 siRNAs for   
96 h, cells were prepared for immunofluorescence staining using antibodies against Dsn1, Nnf1, or Nsl1 as indicated, and chromosomes were stained   
with DAPI. Bar, 10 µM. (B) Maximum fluorescent signals at kinetochores were quantified using ImageJ (see Materials and methods) for each of the indi-
cated antigens. A mean of 96 kinetochores from multiple cells was used to calculate the mean values and are plotted with error bars that represent the   
standard deviation.265 Hsp90-Sgt1 targets the Mis12 kinetochore complex • Davies and Kaplan
regulated by Sgt1 and Hsp90. Importantly, these results also 
argue against Aurora B being the relevant Sgt1 target with   
respect to Mis12 complex assembly, as elevated Aurora B is 
predicted to enhance Mis12 complex recruitment to the kineto-
chore (see Discussion; Yang et al., 2008). Finally, we checked 
if the reported link between Sgt1 and the Drosophila Polo-
like kinase 1 (Martins et al., 2009) could explain the Mis12   
defect  in  Sgt1-inhibited  cells. We  found  that  inhibition  of 
Polo by siRNA did not alter Dsn1 levels (not depicted), which 
led us to favor the idea that Sgt1 directly affects Mis12 com-
plex assembly.
As a so-called keystone complex, Mis12 contributes to the 
localization of several other kinetochore complexes. If Sgt1 func-
tion is limited to Mis12 complex assembly, we predict that block-
ing Sgt1 function will phenocopy the depletion of individual 
Mis12 subunits. Indeed, inhibition of Sgt1 or Dsn1 reduced 
the kinetochore signals of Ndc80
Hec1, CENP-K, CENP-N, and 
CENP-U but not CENP-A, -C, or -B (Fig. 4, A–D, respectively). 
In the case of CENP-K, CENP-N, and CENP-U, we analyzed 
signals in interphase cells. Interphase CCAN components are 
constitutively loaded and have low turnover rates; these charac-
teristics have been noted previously (McClelland et al., 2007). 
As a result, staining was more robust than in mitotic cells,   
allowing more accurate measurements of fluorescent signals 
closely associated with anti-centromere antigen (ACA) staining 
(Fig. 4, A–D, insets). Importantly, siRNA against Sgt1 and Dsn1 
death compared with the single depletion conditions (unpublished 
data). Collectively, the instability of Dsn1 after Hsp90 or Sgt1 
depletion and the synthetic effect of codepletion argue that 
Hsp90 and Sgt1 function in the same pathway to assemble Mis12 
complexes and target them to the kinetochore.
Sgt1 and Dsn1 similarly affect overall 
kinetochore assembly
It is possible that in addition to Mis12 complexes, Hsp90–Sgt1 
targets other kinetochore complexes or regulators of kineto-
chore assembly. Aurora B is a known Hsp90 client (Miyata 
and Nishida, 2004) and has been found to regulate the local-
ization of Dsn1 and Mis12 complexes during mitosis (Yang 
et al., 2008). To test whether Aurora B activity is affected by 
siRNA of Sgt1, we measured a known target of the kinase 
serine 10 on histone H3 (H3pS10). Immunoblots of extracts   
showed the expected enrichment of H3pS10 after nocodazole 
treatment. Interestingly, depletion of Sgt1 gave rise to an ele-
vated H3pS10 signal detected in immunoblots (Fig. 3 E) and 
by  immunofluorescence  (not  depicted),  but  with  a  similar   
mitotic index to nocodazole-treated cells (Fig. 3 E). In contrast, 
depletion of Hsp90 eliminated the H3pS10 signal (Fig. 3 E), 
a result that is consistent with published reports that Hsp90 is 
required for Aurora B activity (Lange et al., 2002; Terasawa 
and Minami, 2005). The fact that depletion of Sgt1 and Hsp90 
had opposite effects on Aurora B highlights the distinct pathways 
Figure 3.  Sgt1 and Hsp90 coordinately sta-
bilize Mis12 complex protein levels.  (A)  The 
levels  of  Mis12  proteins  were  measured  by 
immunoblot  after  treatment  with  control  or 
Sgt1  siRNAs  for  96  h.  Tubulin  serves  as  a 
loading control and was used to quantify the 
fluorescent immunoblot signals (see Materials 
and methods). Changes in the levels of Mis12 
subunits are expressed as a percentage of con-
trol extracts (set at 100%). (B) After treatment 
with  the  indicated  siRNAs,  Mis12  subunits 
were analyzed by immunoblotting. (C) siRNA 
knockdown efficiency was analyzed for Sgt1 
and Hsp90 as in A. Error bars represent the 
standard deviation derived from multiple blots: 
Sgt1  siRNA  (n  =  4),  Hsp90  RNAi  (n  =  2).   
(D) Dsn1 levels were measured by immunoblot-
ting after treatment with Hsp90 or Hsp90 and 
Sgt1 RNAi for 48 h. Protein levels were ana-
lyzed as in A. (E) Immunoblots with antibodies 
to  histone  H3  phospho-serine  10  (H3pS10) 
and Aurora B after siRNA knockdown of Sgt1 
or Hsp90 levels for 72 h. The percentage of 
mitotic cells observed at the time of harvest is 
indicated below the blot.JCB • VOLUME 189 • NUMBER 2 • 2010   266
Figure 4.  Sgt1 and Dsn1 target a complementary set of kinetochore proteins. (A–D) HeLa cells were treated with control, Sgt1, or Dsn1 siRNAs for 72 h   
and prepared for immunofluorescence analysis using antibodies to Ndc80
Hec1, CENP-K, CENP-N, CENP-U, or ACA as indicated. Chromosomes were 
stained with DAPI. Insets highlight the kinetochore foci indicated by the small arrows in the merged image and are enlarged 3.5-fold. Bars: (main panels) 
10 µm; (insets) 1 µm. (E) Fluorescent signals were quantified as in Fig. 1 D. P-values were <0.05 for all treated samples with the exception of CENP-U, which 267 Hsp90-Sgt1 targets the Mis12 kinetochore complex • Davies and Kaplan
infected insect cells (Fig. 6 C and Materials and methods). 
Glycerol gradient sedimentation indicated that the bulk of Mis12 
subunits migrate at the expected position for a properly assem-
bled multiprotein complex (Fig. S1 A). We incubated purified 
Mis12 complex with two amounts of bead-bound GST-Sgt1 and 
visualized associated proteins. At low GST-Sgt1 levels (0.5 µM), 
we  observed  a  specific  and  significant  association  with  the 
Mis12 subunits, Dsn1 and Nsl1; at higher levels of GST-Sgt1 
(1.0 µM), we observed enhanced Dsn1 and Nsl1 binding and 
now significant levels of the Mis12 and Nnf1 subunits (Fig. 6 D). 
We conclude that Sgt1 can directly interact with the Mis12 
complex and that it may have a higher affinity for the Dsn1 and 
Nsl1 subunits.
We next examined the interaction between Mis12 com-
plex and Hsp90. Mis12 complexes were incubated with GST-
Hsp90 in the presence of ADP or the nonhydrolyzable ATP 
analogue, AMP-PNP. In the absence of Sgt1, we observed very 
weak  binding  of  Nsl1  and  Dsn1  independent  of  nucleotide   
(Fig. 6 E; Sgt1 lanes). We observed similar weak binding of 
Nsl1 and Dsn1 in the presence of 0.5 µM or 1.0 µM Sgt1 and 
either AMP-PNP (Fig. 6 E) or 17-AAG (Fig. S2 C). Strikingly, 
binding of Mis12 complex to GST-Hsp90-ADP was dramati-
cally enhanced after titrating in >1.0 µM Sgt1 (Figs. 6 E and   
S1 C). A similar result was obtained for Mis12 complexes iso-
lated in glycerol gradient fractions (Fig. S1, A and B), which   
argues that under these conditions, GST-Hsp90 can interact with 
intact Mis12 complex and is not simply binding to misfolded 
reduced the kinetochore-associated signals of both inner and 
outer complexes to a similar extent (Fig. 4 E). In contrast, our 
findings and previously published work show that depletion 
of either the CENP-H complex component, CENP-K, or the 
microtubule-binding component Ndc80
Hec1, does not affect Mis12 
complex localization (unpublished data; Cheeseman et al., 2006; 
Kline et al., 2006). The shared set of localization defects ob-
served after inhibition of Sgt1 or Dsn1 favor the idea that Sgt1 
acts solely on the Mis12 complex.
The global defects in kinetochore assembly after inhibi-
tion of either Sgt1 or Dsn1 led us to ask if defects arise simply 
from protein mislocalization or if the link between misassembly 
and protein turnover extends to non-Mis12 kinetochore com-
plexes. We found that siRNA directed against either Sgt1 or 
Dsn1 destabilized Ndc80
Hec1, CENP-H, and CENP-K (Fig. 5 A).   
In contrast, CENP-N levels were only modestly affected, and 
CENP-U (CENP-O complex) levels did not change. The re-
ported interaction between Mis12 and Ndc80
Hec1 (Cheeseman 
et al., 2006), but not with CENP-N and CENP-U, is consistent 
with the idea that the assembly of other kinetochore complexes 
is linked to their stability. Importantly, siRNA directed against 
CENP-U or CENP-K (45% and 75% knockdown, respectively) 
did not significantly affect the levels of Mis12 subunits or 
Ndc80
Hec1, making it unlikely that Sgt1 indirectly affects Mis12 
complex stability (Fig. 5 B). We conclude that global kineto-
chore assembly defects after inhibition of Sgt1 or Mis12 com-
ponents likely arise from the turnover of misassembled or 
unassembled complexes (see Discussion).
Sgt1 binds to and enhances Mis12 
complex association with Hsp90
The  genetic  experiments  presented  strongly  argue  that  the 
Mis12 complex interacts with Hsp90–Sgt1 as a client. To more 
directly test the chaperone–client relationship, we immunopuri-
fied Dsn1 from extracts of cells that had been arrested in mitosis 
with nocodazole and immunoblotted for Hsp90 or Sgt1; this 
interaction was observed in cycling cells but was less robust 
(unpublished data). We observed a modest but significant co-
purification of Hsp90 and Sgt1 with Dsn1, which is typical of 
levels observed with Hsp90 clients in cell extracts (Fig. 6 A; 
Hartson et al., 1999; Whitesell et al., 1998; Arlander et al., 
2006). Consistent with its proposed role as a client adaptor 
(Catlett and Kaplan, 2006), 48 h of depletion of Sgt1 (to 36% of 
control) reduced the levels of Hsp90 that copurified with Dsn1 
by >50% (Fig. 6 A). In addition, the fact that Hsp90 did not co-
purify with CENP-K or Ndc80
Hec1 argues that its interaction 
with the Mis12 complex is specific and likely to occur before 
Mis12 incorporation into kinetochores (Fig. 6 B).
To study the Hsp90–Sgt1 interaction with the Mis12 com-
plex in more detail, we separately purified recombinant Mis12 
complex (His6-Dsn1, Nsl1, Nnf1, and Mis12), human GST-Sgt1 
expressed in bacteria, and GST-Hsp90 expressed in Baculovirus-
exhibited a high degree of signal variation. Error bars represent the deviation from the mean observed in multiple kinetochores and cells. (F) Diagram of 
kinetochore–protein interactions based on our genetic analyses and published data (Foltz et al., 2006; Okada et al., 2006; Cheeseman et al., 2008). The 
Mis12 complex and arrows are highlighted in red to represent potential direct or indirect interaction pathways within the kinetochore network.
 
Figure 5.  Inhibition of Sgt1 and Mis12 subunits gives rise to identical 
kinetochore defects. (A) HeLa cells were treated with control, Sgt1, or Dsn1 
siRNAs for 72 h. Cell extracts were analyzed by immunoblotting to deter-
mine the levels of inner (CENP-K, -H, -U, and -N) and outer kinetochore 
proteins Ndc80
Hec1. (B) HeLa cells were treated with control, CENP-U, and 
CENP-K siRNAs for 72 h, and extracts were analyzed by immunoblotting 
as in A using the indicated antibodies. For A and B, tubulin was used as 
a loading control, and brackets indicate CENP-U–specific bands. Asterisks 
represent nonspecific staining.JCB • VOLUME 189 • NUMBER 2 • 2010   268
Figure 6.  In vitro biochemical assays of the Sgt1–Hsp90 and Mis12 complex interactions. (A) HeLa cell extracts were subject to immunopurification (IP) 
after 48 h of treatment with control or Sgt1 siRNA and arrested for 16 h in nocodazole, using antibodies to Dsn1. The starting extract (L), the IP, and the 
post-IP supernatant (FT) were analyzed by immunoblotting using the indicated antibodies (labeled on the right side of the gel). (B) HeLa cell extracts were 
analyzed as in A, except that either Ndc80
Hec1 or CENP-K was used for the immunoprecipitation. The immunoblot in the top panel was probed with anti-
bodies against both Ndc80
Hec1 and Hsp90. (C) The indicated proteins or Mis12 complex (referred to as Mis12) were purified, analyzed on SDS-PAGE, and 
stained with Coomassie dye. The migration position and cleavage products provide a reference for the same material used in the binding assays. The arrow 
labeled GST indicates the migration of cleaved GST; the arrow labeled prot indicates the migration position of the protease used to cleave GST from the 
fusion. *, the migration position of cleaved GST-Sgt1; **, the migration position of Sgt1 degradation. The diagram provides a key to complexes illustrated 
in the binding assays that follow. (D) The indicated µM concentration of GST-Sgt1 or GST were bound to glutathione beads and then used in the binding 269 Hsp90-Sgt1 targets the Mis12 kinetochore complex • Davies and Kaplan
assay by adding Mis12 complex to 0.5 µM; complexes were identified that were associated with glutathione beads bound to the fusions. The diagram 
below the gel summarizes the binding observed, and the grayed subunits exhibit lower or nonspecific binding. Analysis of unbound fractions is included in 
Fig. S1. (E) GST-Hsp90 was preincubated with the indicated nucleotide (see Materials and methods) and then bound to the Mis12 complex in the presence 
or absence of Sgt1. Diagrams below the gels summarize the binding results. Numbers next to the gel blots indicate molecular mass in kD.
 
proteins. These results are consistent with work on yeast com-
plexes (Catlett and Kaplan, 2006) and demonstrate the con-
served preference of the human Sgt1 for the ADP-bound form 
of human Hsp90. We also conclude that Sgt1 binds to Mis12   
independently of Hsp90 and can mediate the formation of   
an Hsp90-ADP-Sgt1-client cocomplex, supporting a model 
whereby Sgt1 binds to Mis12 subunits and targets them to 
Hsp90 (see Discussion).
Skp1 balances Sgt1-dependent Mis12 
complex stability with turnover
In budding yeast, turnover of the Hsp90–Sgt1 client complex 
CBF3 is linked to the SCF E3-ubiquitin ligase (Kaplan et al., 
1997). In both yeast and human systems, Skp1 is an essential 
component of SCF and interacts with Sgt1 (Skowyra et al., 
1997; Lyapina et al., 1998; Michel and Xiong, 1998; Yu et al., 
1998; Zhang et al., 2008). To test if Skp1 and SCF are involved 
in the turnover of Mis12 complexes, we used double siRNA 
treatment. We reasoned that if Mis12 complex turnover requires 
SCF function, then Skp1 depletion should stabilize Mis12 sub-
units in the absence of Sgt1. Sgt1 siRNA alone results in re-
duced levels of Dsn1 and Ndc80
Hec1 on mitotic kinetochores 
(Fig. 7, A and B) and increased frequency of misaligned chromo-
somes (Fig. 7 C). Strikingly, cotransfection of HeLa cells with 
Sgt1 and Skp1 siRNAs (see Fig. 7 D for Skp1 knockdown 
efficiency) suppressed the defect in Dsn1 and Ndc80
Hec1 kineto-
chore localization (Fig. 6, A and B). The increase in kinetochore 
signals is accompanied by stabilization of protein levels (Fig. 8) 
and by formation of functional kinetochores, as indicated by a 
reduction in the frequency of cells with misaligned chromo-
somes (Fig. 7 C). Sgt1 levels remain low in the double siRNA-
treated cells, which demonstrates that Skp1 does not rescue 
kinetochore defects by stabilizing Sgt1 (Fig. 8 E). Collectively 
these results suggest that Hsp90–Sgt1, together with Skp1, act 
in a conserved pathway that balances kinetochore complex sta-
bility with turnover.
Hsp90–Sgt1 and Skp1 ensure efficient 
formation of high-affinity kinetochore–
microtubule attachment sites
Overall,  our  findings  are  consistent  with  Sgt1  and  Hsp90   
being  important  for  the  efficient  formation  of  kinetochore– 
microtubule sites. Sgt1 or Dsn1 siRNA reduce but do not elimi-
nate kinetochore-bound (Fig. 4, A and E) and soluble pools of   
Ndc80
Hec1 (Fig. 5 A). Our observations as well as published data 
demonstrate only a partial chromosome alignment defect after 
Sgt1 or Dsn1 siRNA treatment. The partial chromosome align-
ment defects could arise because only some centromeres have 
formed fully functional microtubule attachment sites or because 
partially functional sites have formed on all centromeres. To   
begin to distinguish between these possibilities, we imaged 
various kinetochore markers after treatment of cells with Sgt1 
siRNA. We found that all chromosomes contained reduced Dsn1 
signal in the absence of Sgt1; quantification of individual kineto-
chore signals showed a very narrow distribution that clustered 
near the low end of signals found in control cells (Fig. 8 A).   
We then compared the intensities of Dsn1 on chromosomes that 
appeared aligned with those that had clearly failed to align at 
the metaphase plate (i.e., misaligned chromosomes); we ob-
served that misaligned chromosomes have on average lower 
Dsn1 signals compared with signals on aligned chromosomes 
(Fig. 8 B). To determine if the assembly of Mis12 complexes 
is simply delayed (i.e., less efficient) in the absence of Sgt1, 
we analyzed post-metaphase cells after Sgt1 or Dsn1 depletion.   
Although depletion of Sgt1 results in enrichment in mitotic cells, 
a significant percentage of these cells proceed past metaphase 
(Fig. S3 C). Interestingly, in these early anaphase cells, Dsn1 
levels return to near normal levels, arguing that assembly and 
recruitment of Mis12 complexes to the kinetochore is delayed 
in the absence of Sgt1. Although we cannot rule out that Sgt1   
depletion is less efficient in those anaphase cells, the hetero-
geneity in Dsn1 signals contrasts with the situation in control cells 
and argues that these cells originated from metaphases with de-
fective kinetochores. In addition, the behavior of anaphase cells 
after Sgt1 depletion contrasts with Dsn1 depletion, which have 
fewer cells that proceed past metaphase, maintain low levels of 
Dsn1, and exhibit lagging chromosomes in anaphase (Fig. S3, 
C and D). We take these data to indicate that Sgt1 is required for 
the timely assembly of Mis12 and kinetochore complexes.
The delayed assembly of Mis12 complexes is predicted 
to  compromise  the  formation  of  kinetochore–microtubule 
binding sites. To test this possibility, we cold-treated control 
siRNA-treated cells so that only kinetochore microtubules that 
had made stable plus-end attachments were preserved (Salmon 
and Begg, 1980). In control cells, a robust spindle structure 
was preserved in metaphase cells, and bundles of microtubules 
were observed to terminate in kinetochores (Fig. 8 D). In con-
trast, Sgt1-depleted cells with partially aligned chromosomes 
exhibited disorganized spindle structures, with many kineto-
chores showing a complete absence of microtubule attachments   
(Fig. 8 C, arrowheads). We also observed a range of defects 
among treated mitotic cells, with some cells having nearly nor-
mal spindle structures (Fig. 8 C, top), a heterogeneity that we 
argue is consistent with the delayed formation of functional 
microtubule-binding sites. In contrast to these heterogeneous 
microtubule attachment defects, reduction in Ndc80
Hec1 prevents 
nearly all microtubule bundles after cold treatment (Fig. 8 D, 
bottom). These results support the idea that Hsp90–Sgt1 is re-
quired, through stabilization of Mis12 complexes, to ensure the 
efficient formation of microtubule attachment sites.
We next considered the possibility that the turnover of Mis12 
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that high-affinity attachment sites form with normal kinetics, but 
that there are fewer per kinetochore (see Discussion). Together, 
these observations suggest that Skp1-mediated turnover of Mis12 
complexes serves a nonessential role in ensuring optimal num-
bers of functional microtubule-binding sites.
Discussion
In this work, we sought to identify the kinetochore targets of 
mammalian Hsp90–Sgt1 to gain insight into the mechanism of 
chaperone-mediated kinetochore assembly. We found that Sgt1 
binds to and targets the Mis12 complex to Hsp90 and is required 
for Mis12 stability and kinetochore association. Turnover of 
Mis12 complexes depends on the SCF ubiquitin ligase subunit, 
Skp1. Reminiscent of kinetochore complexes in budding yeast, 
we found that the balance of assembly and turnover directly 
contribute to kinetochore function in mammalian cells. Hsp90–
Sgt1–mediated assembly of Mis12 complexes is necessary for 
the timely formation of high-affinity microtubule-binding sites, 
whereas the turnover of Mis12 complexes is required to ensure 
the proper number of microtubule attachments. We propose that 
complexes, thus ensuring the fidelity of microtubule binding 
site formation. Inhibition of Skp1 alone did not obviously   
affect chromosome alignment or increase the number of lagging 
chromosomes in anaphase (unpublished data). We did observe a 
modest increase in the number of cells with multipolar spindles, 
which is consistent with the reported role of Skp1 and SCF in 
centrosome integrity (unpublished data; Murphy, 2003). Analy-
sis of protein levels by immunoblotting shows an elevation of 
Nsl1, Nnf1, and Mis12 but not Dsn1 in cells treated with Skp1 
siRNA (Fig. 8 E). Although we found an increase in Mis12 
complexes at the kinetochore (Fig. 8 F), there was no overall in-
crease in the levels of Ndc80
Hec1 (Fig. 8 F), which suggests that 
the additional Mis12 complexes are only partially functional. To 
evaluate whether partially functional Mis12 complexes might 
compromise microtubule attachments, we analyzed cold-stable 
microtubules.  Surprisingly,  we  observed  fewer  cold-stable   
kinetochore–microtubule bundles after siRNA against Skp1 
(Fig. 8 G, arrows; and Fig. S3). Even where kinetochores 
retained cold-stable microtubules, these were less robust than 
control cells. The decrease in the robustness of kinetochore–
microtubule attachments but otherwise normal alignment suggests 
Figure 7.  Skp1 is required for Mis12 complex turnover after Sgt1 siRNA. (A) HeLa cells were treated with control, Sgt1, and Sgt1+Skp1 siRNAs for   
72 h. Cells were processed for immunofluorescence with antibodies against tubulin, Dsn1, and ACA; chromosomes were stained with DAPI as indicated. 
Bar, 10 µM. (B) Fluorescent values from Dsn1 or Ndc80
Hec1 signal were quantified for the indicated siRNA treatments. The mean intensities of control siRNA 
for multiple kinetochores, cells, and experiments were set at 100%. The error bars represent the deviation from the mean and are consistent with results from 
multiple experiments. (C) Metaphase-type cells with misaligned chromosomes (see the example in A; Sgt1 siRNA) were counted for the indicated siRNA 
treatments and divided by the total number of metaphase cells (n = 50 cells for each treatment group). (D) siRNA knockdown efficiency of Skp1 was ana-
lyzed by immunoblotting, quantified, and compared with control protein levels. Error bars represent the standard deviation over multiple blots (n = 6).271 Hsp90-Sgt1 targets the Mis12 kinetochore complex • Davies and Kaplan
Hsp90–Sgt1 targets Mis12 complexes
The argument that the Mis12 complex is the main client of the 
Hsp90–Sgt1 chaperone complex is based on both genetic and 
the balance of complex assembly and turnover mediated by 
Hsp90–Sgt1 and SCF ensures the fidelity of the microtubule-
binding site.
Figure  8.  The  balance  of  assembly  and  turnover  of  Mis12  complexes  contributes  to  the  efficiency  and  distribution  of  microtubule  attachment  sites.  
(A) The fluorescent signal associated with Dsn1 at kinetochores was quantified in cells treated with control (blue) or Sgt1 siRNA (green). Signals for each 
kinetochore from multiple mitotic cells are represented in the scatter plot. The fluorescent cell images are examples of the data used for the plot. (B) The 
fluorescent signals from kinetochores only from cells treated with Sgt1 siRNA were divided into two populations: those from kinetochores of aligned or 
misaligned chromosomes. The signals from these two populations are represented in a scatter plot. The grayscale images on the right highlight the boxed 
regions as examples of Dsn1 fluorescence from aligned or misaligned kinetochores. After treatment with Sgt1 (C), control, or Ndc80
Hec1 (D) siRNAs, cells 
were briefly cold-treated to destabilize nonkinetochore microtubules (see Materials and methods). Cells were processed for immunofluorescence and stained 
for tubulin, ACA, and chromosomes with DAPI. Multiple images for cells treated with Sgt1 siRNA exemplify the heterogeneity of kinetochore defects.     
Arrows indicate unattached kinetochores. (E) HeLa cells were treated with control, Sgt1, or Sgt1 and Skp1 siRNAs for 72 h, and extracts were subject to   
immunoblot analysis of the indicated proteins. The fluorescent signals associated with the indicated proteins (Dsn1, Nsl1, Mis12, and Nnf1) were quantified, 
and control treatment was set to 100%. Signals were normalized to tubulin, which serves as a loading control. (F) After treatment of HeLa cells with control 
or Skp1 siRNA and processing for immunofluorescence, the maximum fluorescent intensities of kinetochore-associated Dsn1, Nnf1, and Ndc80
Hec1 from mul-
tiple mitotic cells were quantified. P-values were obtained from a two-tailed Student’s t test. (G) HeLa cells were treated with control or Skp1 siRNAs for 72 h   
and briefly cold-treated to eliminate non–kinetochore-bound microtubules. Cells were processed for immunofluorescence and stained with ACA and tubulin 
antibodies. Arrows indicate kinetochores with little or no associated microtubule signal. Bars: (A and B, left) 10 µm; (B, right) 1 µM; (C, D, and G) 10 µM.JCB • VOLUME 189 • NUMBER 2 • 2010   272
biochemical evidence. The Mis12 subunit, Dsn1, is the first   
kinetochore protein to exhibit decreased levels after treatment 
of cells with the Hsp90 inhibitor, 17-AAG. There are numerous 
examples of degraded Hsp90 clients; the likely explanation is 
that the failure of Hsp90 to release or bind its client results   
in ubiquitin-mediated degradation. Similar to treatment with 
17-AAG, siRNA of Sgt1 causes a dramatic decrease in Dsn1 but 
also results in the loss of Nsl1 and a significant decrease in the 
other Mis12 subunits, Nnf1 and Mis12. Our interpretation is 
that Sgt1 mediates the targeting of Dsn1 and Nsl1 to Hsp90; in 
the absence of targeting and presumably assembly, Nnf1 and 
Mis12 become susceptible to destruction machinery as well.   
Although we cannot rule out the possibility that Hsp90–Sgt1 
has an additional client in the kinetochore, the fact that Dsn1 
siRNA mimics the Sgt1 siRNA defects in kinetochore complex 
stability and recruitment strongly argues that the Mis12 com-
plex is the main client responsible for kinetochore defects.
The biochemical reconstitution of human Hsp90, Sgt1, 
and Mis12 clearly shows that the Sgt1 and Mis12 complexes 
both interact with Hsp90-ADP, and this argues for the formation 
of a cocomplex between Hsp90-ADP and the Sgt1 and Mis12 
subunits. The fact that Sgt1 can bind independently to Mis12 
subunits and enhance the affinity of the Mis12 complex for 
Hsp90 is consistent with the client adaptor function previously 
proposed for yeast Sgt1 (Catlett and Kaplan, 2006). Our bio-
chemical reconstitution took advantage of the stable and soluble 
behavior of an assembled Mis12 complex coexpressed in bacte-
ria (unpublished data; Cheeseman et al., 2006; Kline et al., 
2006). Despite starting with a fully assembled Mis12 complex, 
we observed an enrichment of the Dsn1-Nsl1 subunits associ-
ated with Hsp90–Sgt1. In the absence of Sgt1, Hsp90 binds low 
levels of Dsn1 and Nsl1 but not Nnf1 or Mis12. Interestingly, 
this occurs independently of nucleotide and may represent a 
weak initial interaction between Hsp90 and client that is stabi-
lized by Sgt1 and ADP. Further examination of Hsp90–Sgt1   
interactions with Mis12 subcomplexes and individual subunits 
will be important for ordering the steps of chaperone complex 
formation. Although we speculate that Hsp90–Sgt1 aids in Mis12 
complex  assembly,  our  data  specifically  shows  that  the  two 
complexes interact and that inhibition of either Sgt1 or Hsp90 
leads to protein turnover. Again, reconstitution of the complete 
client–chaperone complex with individual Mis12 subunits will 
be required to understand the precise role of Hsp90–Sgt1 in 
Mis12 complex assembly.
One of the more intriguing observations presented here is 
that siRNA of Skp1 suppresses the Mis12 complex instability 
induced by siRNA of Sgt1. We argue that Sgt1 is required for 
Mis12 complex stability, presumably by mediating complex as-
sembly. Our results are also consistent with the idea that Skp1 
and SCF are involved in the turnover of the Mis12 complex. 
Indeed, siRNA of Skp1 alone results in a modest but significant 
increase in the levels of Mis12 subunits in extracts as well as 
those recruited to the kinetochore. As SCF has a broad range 
of substrates, understanding its specific role at the kinetochore 
will require identifying the F-box subunit that targets Mis12 
complexes. Regardless of which SCF complex is involved, it 
is striking that the same balance between stability and turnover 
that controls CBF3 levels and function in budding yeast also 
plays a role in human kinetochore function.
Balance of keystone Mis12 complex 
stability with turnover
The Mis12 complex has been described as a “keystone” kineto-
chore complex (Cheeseman and Desai, 2008), as it makes con-
tacts with several other kinetochore complexes both proximal 
(e.g., CENP-H) and distal (e.g., Ndc80
Hec1) to the centromeric 
DNA. In its role as a keystone complex, Mis12 complex is 
proposed to act as a node in the context of a network of pro-
tein complexes (Knl1, Ndc80, and motors) that form low- 
and high-affinity microtubule attachment sites. Although it is 
unclear  what  properties  make  the  Mis12  complex  uniquely 
require  Hsp90  function,  one  interestingly  possibility  is  that 
chaperone activity is required for appropriate protein contacts 
between Mis12 subunits and other kinetochore complexes. In 
this scenario, when Dsn1 or another Mis12 subunit binds to 
Hsp90–Sgt1, a stable interaction surface may be exposed that 
is required for the ordered assembly of other Mis12 proteins as 
well as interactions with other kinetochore complexes. In prin-
ciple, mistakes in this process would result in incorrectly formed 
subcomplexes that either fail to get recruited to the kinetochore 
or fail to form robust microtubule-binding networks. In the case 
of treatment with Skp1 siRNA, we observed stabilized Mis12 
subunits and an increase in fluorescent intensity at kinetochores 
but no increase in Ndc80
Hec1 at kinetochores. Indeed, analysis 
of cold-stable kinetochore–microtubules argues that although 
kinetochore–microtubule attachments form efficiently when 
Skp1 is inhibited, they are less robust than controls. Our inter-
pretation of this result is that improperly assembled complexes 
are recruited to kinetochores and form nonoptimal microtubule 
attachment sites. In this light, a more detailed characterization 
of Mis12 complexes that form in the absence of Skp1 or Sgt1 
will be informative.
The characteristics of the Mis12 complex that support its 
role as a keystone kinetochore complex are shared with the CBF3 
complex, the Hsp90–Sgt1 client in budding yeast. It is possi-
ble that the Mtw1 complex in yeast, which is homologous to 
the Mis12 complex in humans, is also an Hsp90–Sgt1 client. 
However, interactions between the Mtw1 complex and Hsp90–
Sgt1 have not been reported, and sequence conservation is poor 
between the human and yeast subunits (15% or less for between 
subunits; unpublished data). The CBF3 complex may be more 
functionally similar to human Mis12 complex, as it also plays a 
“keystone” like role, recruiting multiple kinetochore complexes 
to centromeric DNA. Like Mis12 complexes, CBF3 has been 
shown  to  have  multiple  protein–protein  contacts  within  the 
CBF3 complex and with other proteins, including but not lim-
ited to Cep3, Ctf13, Okp1, Bir1, and Smt3 (sumo) (Ortiz et al., 
1999; Gillis et al., 2005; Montpetit et al., 2006). Indeed, mu-
tants that affect CBF3 assembly can alter the stability of associ-
ated protein complexes (including Bir1 and Sli15; Thomas and 
Kaplan, 2007), similar to the behavior of the Mis12 complex 
observed in this work. We speculate that like the Mis12 com-
plex in human cells, CBF3 also requires the Hsp90–Sgt1 chap-
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with the following variations. Bead-bound GST-Hsp90 was incubated in 
binding buffer (25 mM Tris, pH 8.0, 150 mM KCl, 0.05% Triton X-100, 
10% glycerol, 1 mM dithiothreitol, 10 mM MgCl2, and protease inhibi-
tors as described above) plus 10 mM ATP for 1 h, rinsed twice in binding 
buffer, and then used in binding assays as previously described for 2 h at 
37°C. Bead-bound fractions were suspended in Laemmli buffer, resolved 
on 12.5% SDS-PAGE, and stained in Gel-Code Blue (Thermo Fisher Scien-
tific). The stained SDS-PAGE gels were scanned and quantified using the 
Odyssey system as recommended by the manufacturer.
Immunoprecipitation reactions were performed from Hela cell ex-
tracts prepared in lysis buffer as described above. Cells were treated with 
100 ng/ml nocodazole for 16 h before extraction to enrich for mitotic 
cells.  Protein  concentrations  of  extracts  were  measured  by  a  Bradford   
assay. For each reaction, 4 µg of primary antibody was incubated with 
2.5 mg of Hela cell extract suspended in 200 µl of lysis buffer containing 
10 mM ADP, 10 mM MgCl2, and protease inhibitors for 2 h at 4°C. 10 µl 
of protein A–sepharose CL-4B (Sigma-Aldrich) was added and incubated 
for 1 h at 4°C. Beads were rinsed four times in 500 µl of lysis buffer and 
resuspended in Laemmli buffer for SDS-PAGE and Western transfer.
Immunofluorescence and image acquisition
Cells were grown on coverslips under the culture conditions described 
above. Fixation and processing of coverslips for staining was performed 
in PHEM buffer (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, and 2 mM 
MgCl2,  pH  6.9)  and  4%  formaldehyde  as  described  previously  (Kline 
et al., 2006), with the exception of CENP-K and CENP-U analysis. For 
staining of CENP-U and CENP-K, coverslips were prepared by fixing cells   
in absolute methanol at 20°C for 20 min. Cells were rinsed 3× in PBS in 
between incubations. Primary and secondary incubations were conducted 
for 1 h at room temperature in PBS containing 0.1% Triton X-100 and 
10% BSA. For cold-stable analysis, cells were incubated on ice for 15 min 
in Opti-MEM, then fixed for 10 min on ice followed by 10 min at room 
temperature using PHEM buffer containing 4% formaldehyde and 0.2% 
Triton X-100. Cells were then processed as above. Goat anti–mouse IgG 
Alexa Fluor 594 or 498 (Invitrogen)-, goat anti–rabbit IgG Alexa Fluor 
594 (Invitrogen)-, or goat anti–human IgG Cy5 (Jackson ImmunoResearch 
Laboratories, Inc.)-conjugated secondary antibodies were used at 1:200. 
See Table S1 for primary antibody working dilutions.
Images were collected at room temperature using an inverted micro-
scope (IX 70; Olympus) fitted to a Deltavision RT imaging system (Applied 
Precision). Images were recorded using a 60× NA 1.4 oil immersion lens 
and a CoolSnap HQ camera (Roper Industries). Deconvolution was per-
formed using the SoftWorx v 3.5.1 software package (Applied Precision). 
Measurements of kinetochore intensities were conducted using maximum 
intensity projections of deconvolved images. Kinetochore exposure settings 
were held constant within each group of experiments, and kinetochore sig-
nals within each figure were scaled equally. Maximal kinetochore intensi-
ties and corresponding background levels were measured from radial   
7 × 7 pixel areas for each kinetochore foci using ImageJ version 1.42 soft-
ware (http://rsb.info.nih.gov/ij/) and exported to Excel software (Micro-
soft) for analysis. A minimum of 6 cells and 12 kinetochore foci per cell 
were measured for each condition (each experiment was replicated a mini-
mum of three times). Kinetochore foci intensities were then pooled within 
a given experiment, and the mean kinetochore fluorescence intensity was   
calculated. Statistical significance was evaluated by a two-tailed Student’s 
t test; results with p-values <0.05 were considered statistically significant.
Online supplemental material
Fig. S1 is an analysis of recombinant Mis12 complex purity and composi-
tion by glycerol gradient followed by in vitro binding analysis to Hsp90–
Sgt1 and an analysis of Sgt1-dependent Mis12 complex binding. Fig. S2   
contains unbound fractions from binding assays depicted in Fig. 5. In addi-
tion, an Hsp90–Sgt1–Mis12 complex binding assay conducted in the 
presence of 17-AAG is provided. Fig. S3 contains single z projections of 
microtubule attachment site defects seen in Skp1-treated Hela cells. Con-
trol, Dsn1, and Sgt1 siRNA-treated anaphase cells are also provided to 
illustrate the increase in kinetochore-bound Dsn1 during anaphase in Sgt1 
depleted cells. Table S1 lists antibodies used in this study. Table S2 lists 
siRNA reagents. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.200910036/DC1.
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CENP-N, Topher Carroll for antibodies against CENP-H, and Simon Chan 
and Daniel Starr for reading and providing feedback on the manuscript.
both at the intracomplex level and between other protein com-
plexes. We argue that this property is critical for the ability of 
CBF3 to carry out multiple, distinct mitotic functions. It will be 
interesting  to  determine  if  Mis12  complexes  carry  out  non-
kinetochore functions. For example, inhibition of Mis12 com-
ponents in fission yeast has been reported to alter chromatin 
organization during mitosis (Nakazawa et al., 2008). Further 
analysis of Mis12 complex siRNA phenotypes in mitosis as 
well as anaphase will be required to address this possibility.
Materials and methods
Cell culture, siRNAi transfection, and Hsp90-inhibitor treatments
Hela  cell  cultures  were  maintained  in  DME  supplemented  with  gluta-
mine, sodium pyruvate, penicillin-streptomycin (Invitrogen), and 10% FBS 
(Sigma-Aldrich).
Hsp90 inhibitor 17-AAG (Kosan Biosciences) solubilized in DMSO, 
or a DMSO vehicle control, were added to fresh media and then to cell 
cultures seeded at 50% confluency at dosages of either 100 nM or   
500 nM, as indicated. Cell cultures treated with siRNA were transferred 
from DME to Opti-MEM, then supplemented with glutamine before siRNA 
transfection. siRNA reagents were obtained from Thermo Fisher Scientific 
and transfected at the indicated concentrations (Table S2) using Oligo-
fectamine in Opti-MEM media (Invitrogen). FBS was added to 10% 4–6 h 
after transfection, and cultures were incubated as indicated.
Cloning and expression of recombinant proteins
Isolation of human Sgt1 and Hsp90 was performed by PCR amplification 
from a human leukocyte cDNA library (Takara Bio Inc.). Sgt1 and Hsp90 
were amplified as described previously (Catlett and Kaplan, 2006) to intro-
duce cloning sites allowing ligation into pGEX6-P1 (Invitrogen) or pMIT-77 
(pFASTBAC-GST containing a PreScission protease cleavage site; GE Health-
care) expression vectors, respectively. Coding sequences were verified by 
DNA sequencing before protein expression. Human GST-Sgt1 and human 
Mis12 complex (from a polycistronic vector as described previously; Kline 
et al., 2006) were produced in BL21 DE3 cells using 0.1 mM IPTG to induce 
expression and grown for 5 h at 25°C. Human GST-Hsp90 was expressed 
in insect cells using the Bac-to-Bac expression system (Invitrogen).
Immunoblotting, in vitro binding assay, and immunoprecipitation
For immunoblot analysis, cells treated with siRNA or 17-AAG were rinsed in 
PBS (10 mM Na2HPO4, 2 mM KH2PO4, 137 mM NaCl2, and 3 mM KCl2, 
pH 7.4) and suspended in lysis buffer (10 mM Hepes, pH 8.0, 150 mM   
NaCl, 50 mM -glycerolphosphate, 0.1 mM EDTA, 1% Triton X-100, 1 mM 
dithiothreitol, and 10% glycerol) plus protease inhibitors (1 mM phenyl-
methylsulfonyl fluoride, 1 mM N-tosyl-L-phenylalanine chloromethyl ketone,   
10 µg/ml leupeptin, 10 µg/ml pepstatin, and 10 µg/ml chymostatin). Cells 
were incubated in lysis buffer for 15 min on ice and centrifuged at 14,000 
rpm for 15 min at 4°C, then the soluble fraction was collected for analysis. 
Protein concentrations were measured by a Bradford assay (Bio-Rad Labo-
ratories). For immunoblots, 40 µg of protein was loaded per lane on Nu-
PAGE 4–12% 1.5-mm gradient gels in MES running buffer (Invitrogen) and 
transferred to 0.2 µM nitrocellulose (GE Healthcare) for 5 h in transfer buffer   
(20 mM tris base, 0.2 M glycine, and 20% methanol) at 4°C.
Immunoblots were blocked in 2% nonfat dry milk in PBS for 1 h and 
rinsed briefly in PBS, then primary antibodies were added (see Table S2 
for working concentrations) in PBST-BSA (PBS, 0.01% Tween 20, and 2% 
BSA) for 1–3 h depending on the antigen. Membranes were rinsed three 
times for 5 min in PBST (PBS and 0.01% Tween 20) and secondary anti-
bodies, goat anti–rabbit IgG 800 (LI-COR Biosciences), or goat anti–mouse 
IgG 680 (LI-COR Biosciences), then added 1/10,000 to PBST-BSA and in-
cubated for 1 h. Membranes were rinsed two times for 5 min in PBST and 
once for 5 min in PBS before imaging. Immunoblots were scanned using 
the Odyssey system analyzed using Odyssey software version 3.0 (both 
from LI-COR Biosciences). This method increased blotting sensitivity that 
was not possible using chemiluminescent approaches.
Recombinant proteins were isolated using Ni-NTA agarose (QIAGEN) 
or glutathione affinity chromatography (GE Healthcare), incubated, and 
washed in 1% Triton X-100 lysis buffer to remove contaminating proteins 
and prepared for analysis by SDS-PAGE as described previously (Catlett 
and Kaplan, 2006). Binding assays were conducted as described pre-
viously in a total reaction volume of 200 µl (Catlett and Kaplan, 2006) JCB • VOLUME 189 • NUMBER 2 • 2010   274
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